FR3290M - Nouvelles amines utilisables en thérapeutique, notamment comme inhibiteurs de la mono-aminoxydase. - Google Patents

Nouvelles amines utilisables en thérapeutique, notamment comme inhibiteurs de la mono-aminoxydase.

Info

Publication number
FR3290M
FR3290M FR946496A FR946496A FR3290M FR 3290 M FR3290 M FR 3290M FR 946496 A FR946496 A FR 946496A FR 946496 A FR946496 A FR 946496A FR 3290 M FR3290 M FR 3290M
Authority
FR
France
Prior art keywords
aminoxidase
inhibitors
mono
therapy
new amines
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR946496A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
BASF Schweiz AG
Original Assignee
Ciba Geigy AG
Ciba AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy AG, Ciba AG filed Critical Ciba Geigy AG
Application granted granted Critical
Publication of FR3290M publication Critical patent/FR3290M/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR946496A 1962-06-19 1963-09-04 Nouvelles amines utilisables en thérapeutique, notamment comme inhibiteurs de la mono-aminoxydase. Expired FR3290M (fr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US20343662A 1962-06-19 1962-06-19
US21189462A 1962-07-23 1962-07-23
US267810A US3253037A (en) 1962-06-19 1963-03-25 N-2-alkynyl-amino-benzocylo-alkanes
FR938412 1963-06-18

Publications (1)

Publication Number Publication Date
FR3290M true FR3290M (fr) 1965-05-03

Family

ID=27394548

Family Applications (1)

Application Number Title Priority Date Filing Date
FR946496A Expired FR3290M (fr) 1962-06-19 1963-09-04 Nouvelles amines utilisables en thérapeutique, notamment comme inhibiteurs de la mono-aminoxydase.

Country Status (10)

Country Link
US (1) US3253037A (fr)
AT (2) AT244331B (fr)
BE (1) BE633762A (fr)
BR (1) BR6349933D0 (fr)
CH (3) CH466269A (fr)
DE (1) DE1443599A1 (fr)
ES (1) ES289141A1 (fr)
FR (1) FR3290M (fr)
GB (1) GB1003686A (fr)
SE (3) SE317370B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1187017A (en) * 1966-07-16 1970-04-08 Aspro Nicholas Ltd Substituted 1-Amino Indanes and Tetrahydronaphthalens
US3485874A (en) * 1966-05-04 1969-12-23 Chinoin Gyogyszer Es Vegyeszet Ortho and para bromophenyl isopropyl methylamines
US3852339A (en) * 1970-06-15 1974-12-03 Squibb & Sons Inc Aminoalkoxyphenylurea derivatives
FR2319332A1 (fr) * 1975-07-28 1977-02-25 Roussel Uclaf Nouveaux derives de l'aminobenzocycloheptene et leurs sels, procede de preparation et application a titre de medicaments desdits produits
US4320148A (en) * 1980-11-24 1982-03-16 Smithkline Corporation 2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha1 agonist activity
US4393226A (en) * 1981-05-06 1983-07-12 The Ohio State University Research Foundation Compounds and methods for changing calcium metabolism within the cells of a mammal
US4542153A (en) * 1981-05-06 1985-09-17 The Ohio State University Research Foundation Methods for changing calcium metabolism within the cells of a mammal
US5214156A (en) * 1988-03-25 1993-05-25 The Upjohn Company Therapeutically useful tetralin derivatives
IL114715A (en) * 1989-02-27 1997-01-10 Lilly Co Eli Intermediate compounds for ring-substituted 2-amino-1, 2, 3, 4-tetrahydronaphthalenes and 3-aminochromanes
IL92952A (en) * 1990-01-03 1994-06-24 Teva Pharma R-enantiomers of n-propargyl-1-aminoindan compounds, their preparation and pharmaceutical compositions containing them
US5744500A (en) * 1990-01-03 1998-04-28 Teva Pharmaceutical Industries, Ltd. Use of R-enantiomer of N-propargyl-1-aminoindan, salts, and compositions thereof
US5844003A (en) * 1991-04-04 1998-12-01 Innovations Foundation Use of deprenyl compounds to maintain, prevent loss, or recover nerve cell function
IL112819A (en) * 1991-10-16 2001-11-25 Teva Pharma Fluorinated 1-aminoindan compounds and a process for their preparation
US5877218A (en) * 1994-01-10 1999-03-02 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using 1-aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives
HU225986B1 (en) * 1994-01-10 2008-02-28 Teva Pharma Use of 1-aminoindan derivatives for preparing pharmaceutical compns. and 1-aminoindan derivatives
DE69738275T2 (de) 1996-12-18 2008-08-28 Teva Pharmaceutical Industries Ltd. Aminoindanderivate
US6737547B1 (en) 1998-12-31 2004-05-18 Teva Pharmaceutical Industries, Ltd. Compositions containing and methods of using N-acyl-1H-aminoindenes
US20040010038A1 (en) * 2002-02-27 2004-01-15 Eran Blaugrund Propargylamino indan derivatives and propargylamino tetralin derivatives as brain-selective MAO inhibitors
ATE521343T1 (de) * 2004-11-24 2011-09-15 Teva Pharma Im mund zerfallende zusammensetzungen von rasagilin
NZ564130A (en) * 2005-06-02 2009-12-24 Jenrin Discovery N-propargyl-1-aminoindan compounds useful for treating obesity
US7491847B2 (en) 2005-11-17 2009-02-17 Teva Pharmaceutical Industries, Ltd. Methods for isolating propargylated aminoindans
EP1956904B1 (fr) * 2005-12-09 2017-04-12 Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Ladostigil a faible dose pour le traitement du déficit cognitif léger
TW200744576A (en) * 2006-02-24 2007-12-16 Teva Pharma Propargylated aminoindans, processes for preparation, and uses thereof
EP2053033A1 (fr) 2007-10-26 2009-04-29 Bayer Schering Pharma AG Composants à utiliser dans l'imagerie, le diagnostic et/ou le traitement des maladies du système nerveux central ou des tumeurs
NZ585752A (en) 2007-12-24 2011-11-25 Cipla Ltd Process for the synthesis of propargylated aminoindan derivatives
EP2328861A2 (fr) * 2008-07-11 2011-06-08 Synthon BV Polymorphes de chlorhydrate de rasagiline
EP2657221A1 (fr) 2008-11-20 2013-10-30 Dr. Reddy's Laboratories Ltd. Préparation de rasagiline et ses sels
DK2451771T3 (da) * 2009-07-09 2014-09-08 Ratiopharm Gmbh Salte af rasagilin og farmaceutiske fremstillingsmåder heraf
EP2325159A1 (fr) 2009-11-24 2011-05-25 LEK Pharmaceuticals d.d. Nouveaux sels de rasagiline
EP2610239A1 (fr) 2012-01-02 2013-07-03 Dr. Reddy's Laboratories Ltd. Préparation de rasagiline hémitartrate
WO2017190107A1 (fr) * 2016-04-29 2017-11-02 Board Of Regents, The University Of Texas System Liants de récepteur sigma

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3201470A (en) * 1965-08-17 Chsx c cech

Also Published As

Publication number Publication date
SE321926B (fr) 1970-03-23
CH466269A (de) 1968-12-15
AT244331B (de) 1965-12-27
CH455752A (de) 1968-05-15
US3253037A (en) 1966-05-24
BR6349933D0 (pt) 1973-08-28
SE321676B (fr) 1970-03-16
GB1003686A (en) 1965-09-08
ES289141A1 (es) 1963-11-16
BE633762A (fr) 1963-12-18
CH462154A (de) 1968-09-15
DE1443599A1 (de) 1968-10-24
AT244951B (de) 1966-02-10
SE317370B (fr) 1969-11-17

Similar Documents

Publication Publication Date Title
FR3290M (fr) Nouvelles amines utilisables en thérapeutique, notamment comme inhibiteurs de la mono-aminoxydase.
BE604767A (fr) Nouvelles quinaléines et quinazolines et leurs procédés de préparation.
FR1761M (fr) Nouvelle pyridine, utilisable en thérapeutique, notamment comme antimycotique et désinfectant.
FR3239M (fr) Nouvelles amines substituées.
FR3380M (fr) Nouvelles préparations anthelmintiques, utilisables en thérapeutique.
FR3818M (fr) Nouvel imidazole utilisable en thérapeutique, notamment comme agent antischistosomien et antiamibien.
FR3644M (fr) Nouvelles quinazolines utilisables en thérapeutique, notamment comme analgésiques.
FR1522M (fr) Nouvelles diphényléthylamines substituées.
FR6247M (fr) Nouvelles applications thérapeutiques des épithio-2,3 stéroïdes.
FR1715M (fr) Composition thérapeutique.
FR1910M (fr) Nouvelle hydrazone guanylique, utilisable en thérapeutique, comme agent anti-inflammatoire.
FR2691M (fr) Nouveaux a-nor-b-homo-stéroides utilisables en thérapeutique, notamment comme gestagenes.
FR3308M (fr) Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents anti-inflammatoires.
FR3110M (fr) Nouvelles benzamides.
FR3534M (fr) Nouvelle isoquinoléine utilisable en thérapeutique, notamment comme agent antitussif.
FR1898M (fr) Nouvelle substance utilisable en thérapeutique.
FR3864M (fr) Nouvelles pipérazines utilisables en thérapeutique, notamment comme agents hypotenseurs.
FR1359072A (fr) Nouvelles triamines monotertiaires-diprimaires utilisables comme agents réticulants des résines époxydées
FR3559M (fr) Nouvelles diamines alicycliques.
FR2408M (fr) Nouvelles cétones basiques utilisables en thérapeutique, notamment comme stimulants.
FR2998M (fr) Nouvelles guanidines utilisables en thérapeutique, notamment comme hypoglycémiants.
FR2365M (fr) Nouvelles guanidines utilisables en thérapeutique, notamment comme hypoglycémiants.
FR3015M (fr) Nouveaux a-nor-b-homo-stéroides utilisables en thérapeutique, notamment comme agents anabolisants.
FR2715M (fr) Nouveuax sulfonamides utilisables en thérapeutique, notamment comme agents chimiothérapiques.
FR2331M (fr) Nouvelle 2,3-dihydro-benzofuranne utilisable en thérapeutique, notamment comme agent antihypertensif.